Financials in USD. Standardized financial statements.
A compact view of how Shanghai Pharmaceuticals Holding Co., Ltd turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $283.58B | $275.25B | $260.30B | $231.98B | $215.82B | $191.91B | $186.57B | $159.08B | $130.85B | $120.76B |
| Revenue Growth? | +3.0% | +5.7% | +12.2% | +7.5% | +12.5% | +2.9% | +17.3% | +21.6% | +8.3% | 0.0% |
| Cost of Revenue? | $253.16B | $244.62B | $228.97B | $201.49B | $187.28B | $164.47B | $159.75B | $136.52B | $114.12B | $106.53B |
| Gross Profit? | $30.42B | $30.63B | $31.33B | $30.49B | $28.54B | $27.44B | $26.81B | $22.56B | $16.72B | $14.23B |
| Gross Margin? | +10.7% | +11.1% | +12.0% | +13.1% | +13.2% | +14.3% | +14.4% | +14.2% | +12.8% | +11.8% |
| Operating Expenses? | $20.47B | $22.49B | $23.66B | $21.71B | $20.62B | $19.30B | $18.88B | $16.33B | $11.75B | $9.97B |
| Operating Income? | $9.94B | $8.14B | $7.67B | $9.01B | $8.21B | $7.18B | $8.93B | $5.21B | $5.23B | $4.21B |
| EBITDA? | $14.37B | $12.06B | $10.90B | $12.42B | $11.27B | $9.94B | $9.35B | $6.72B | $6.42B | $5.16B |
| Income Before Tax | $9.82B | $8.02B | $7.05B | $8.81B | $8.14B | $7.18B | $6.26B | $5.34B | $5.20B | $4.64B |
| Income Tax Expense | $2.85B | $2.15B | $1.89B | $1.82B | $1.87B | $1.57B | $1.43B | $887.12M | $1.15B | $809.28M |
| Net Income? | $5.72B | $4.55B | $3.77B | $5.62B | $5.09B | $4.50B | $4.08B | $3.88B | $3.52B | $3.20B |
| EPS? | $1.54 | $1.23 | $1.02 | $1.61 | $1.79 | $1.58 | $1.44 | $1.37 | $1.31 | $1.19 |
| Diluted EPS? | $1.54 | $1.23 | $1.02 | $1.61 | $1.79 | $1.58 | $1.44 | $1.37 | $1.31 | $1.19 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality